Last Updated on October 7, 2024 by The Health Master

Drug alert

Drug alert: Download the list of NSQ samples for June 2024, the link is given below: 61 drug samples declared as not of standard quality (NSQ), nationwide.

NSQ Lists are given below the article

Out of these 61 samples, 31 were declared NSQ by CDSCO and 30 were declared NSQ by various STATES across India.

Details of the NSQ samples declared by STATES is as under:

Sr.	Name of STATES	Number of NSQ samples declared
1	Kerala	7
2	Maharashtra	23
	Total	30

NOTE:

1. NSQ data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Rajasthan (PDF format) and Orissa (PDF Format). for the Month of June, 2024 as per DCG(I) Circular dated 09.02.2024.
2. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh,Goa,Gujarat, Haryana, Himachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry,Telangana,Delhi,Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of June, 2024 as per DCG(I) Circular dated 09.02.2024.

Drug alert: Previous months

May 2024: Out of these 52 samples, 39 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.

April 2024: Out of these 50 samples, 33 were declared NSQ by CDSCO and 17 were declared NSQ by various STATES across India.

During the month of March 2024, the authorities tested 931 samples, out of which 864 were of standard quality. The number of samples declared as not of standard quality was 66, with one being misbranded and none being spurious.

During the month of February 2024, the authorities tested 1167 samples, out of which 1018 were of standard quality. The number of samples declared as not of standard quality was 58, with none being misbranded and two being spurious.

During the month of January 2024, the authorities tested 932 samples, out of which 886 were of standard quality. The number of samples declared as not of standard quality was 46, with none being misbranded and none being spurious.

During the month of December 2023, the authorities tested 1008 samples, out of which 930 were of standard quality. The number of samples declared as not of standard quality was 78, with none being misbranded and none being spurious.

During the month of November 2023, the authorities tested 1197 samples, out of which 1133 were of standard quality. The number of samples declared as not of standard quality was 62, with one being misbranded and one being spurious.

During the month of October 2023, the authorities tested 1105 samples, out of which 1044 were of standard quality. The number of samples declared as not of standard quality was 61, with none being misbranded and none being spurious.

During the month of September 2023, the authorities tested 1188 samples, out of which 1126 were of standard quality. The number of samples declared as not of standard quality was 62, with none being misbranded and none being spurious.

During the month of August 2023, the authorities tested 1166 samples, out of which 1118 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and none being spurious.

During the month of July 2023, the authorities tested 1306 samples, out of which 1252 were of standard quality. The number of samples declared as not of standard quality was 51, with none being misbranded and 3 being spurious.

During the month of June 2023, the authorities tested 1273 samples, out of which 1225 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and one being spurious.

The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, Indore, and Guwahati.

List of Drugs declared as NSQ by CDSCO for the Month of June– 2024.

A. CDSCO/Central Laboratories
S.No	Product/Drug Name	Batch No.	Manufacturing Date	Expiry Date	Manufactured By	NSQ Result	Reported by CDSCO Laboratory
1.	Propylene Glycol I.P.	PG- IP/2023- 24/2355	11/2023	10/2028	M/s. Manali Petrochemicals Ltd., Manali, Chennai- 600068, India	Relative Density	CDL, Kolkata
2.	Propylene Glycol USP/IP	BT1205B0 4072023	07/2023	07/2024	M/s. Balaji Amines Limited, Plot No. F- 104, Chinchoili M.I.D.C., Tq. Mohol, Distt. Solapur – 413 255, Maharastra	Relative Density	CDL, Kolkata
3.	Compound Sodium Lactate Injection I.P., 500 ml (Ringer Lactate Solution for Injection)	P2401050 08	01/2024	12/2025	M/s. Vision Parenteral Pvt. Ltd., A-2-44, 45, Sector-15, GIDA Industrial Area, Gorakhpur -273209 (U.P.), India	Bacterial endotoxins	CDL, Kolkata
4.	Esomeprazole Gastro- Resistant Tablets IP 40 mg (Esomedge- 40)	GD23083	07/2023	06/2025	M/s. GlenSmith Labs Private Limited, Mfg. by: Skymap Pharmaceuticals Pvt. Ltd., B-3, Dev Bhoomi Industrial Estate, Puhana Iqbalpur Road, Roorkee 247 667.	Dissolution	CDL, Kolkata
5.	Gentamicin Sulphate Injection I.P. 2 ml	323-216	03/2023	02/2025	M/s. Zee Laboratories Ltd., Behind 47, Indl. Area, Paonta Sahib – 173025	Description & Particulate matter	CDL, Kolkata
6.	Frusemide Injection IP 2 ml (FRUSEMIDE)	FRA12347	12/2023	11/2025	M/s. Nandani Medical Laboratories Pvt. Ltd., 221/5, Bicholi Hapsi, Kanadia Road, Indore	pH	CDL, Kolkata
7.	Ceftriaxone for Injection I.P. 1 gm	DC30119	10/2023	09/2025	M/s. Captab Biotec Unit-II, Plot No-125, E.P.I.P Road, Mauja Jharmajri, Baddi, Distt.-Solan H.P.	Particulate matter	CDL, Kolkata
8.	Amoxycillin & Potassium Clavulanate Injection IP 1.2 gm	23AP04	05/2023	04/2025	M/s. Sai Parenterals Limited, D1 & D4, Survey No. 280, Phase- V, IDA, Jeedimetla, Hyderabad-500 055, TS.	Clarity of Solution and Assay of Potassium Clavulanate	CDL, Kolkata
9.	Cefixime & Ofloxacin Tablets (CEFIKAM OF 200)	DB230057	02/2023	01/2025	M/s. Daxin Pharmaceuticals Pvt. Ltd., Plot No-121-122, EPIP, Jharmajri Phase-1, Teh. Baddi, Distt. Solan (H.P.) 174 103.	Assay of Cefixime Trihydrate & Assay Ofloxacin	CDL, Kolkata
10.	Propylene Glycol USP	97220141 13	11/2023	10/2028	M/s. Shell Eastern Chemicals, The Metropolis Tower, 1, 9 North Buona, Visla Drive 07 01 Singapore 138588	Specific Gravity	CDL, Kolkata

11.	Ranitidine Hydrochloride Tablets (Ranylaj-150)	GTDE3019	05/2023	04/2025	M/s. Francis Remdies (India) Pvt.Ltd., Vill- Mandawali, Roorkee, Distt. Haridwar (U.K.) 247670	Description	CDL, Kolkata
12.	Glipizide and Metformin Tablets IP (Glynase-MF)	04010026	11/2023	04/2025	M/s. USV Private Limited, At: B-249/B- 250, II Stage, Peenya Industrial Estate, Bangalore-560058	Dissolution of Glipizide	CDL, Kolkata
13.	Exo Cheri (Dextromethorp han Hydrobromide Chlorpheniramin e Maleate Pheylephrine Hydrochloride Cough Syrup)	L/040618	04/2024	01/2026	Exotic Pharma, 91/1, G.I.D.C., GODHRA Dist.- Panchmahal, Gujarat- 389001	pH	CDTL-Mumbai
14.	Etamsylat Tablets 500 mg	ELT1104	02/2024	07/2024	Unicure India Ltd., C- 21, 22 & 23, Sector-3, Noida-201 301, Distt. Gautam Budh Nagar (U.P)	Description	CDTL-Mumbai
15.	Tranexamic Acid Tablets I.P. 500 mg	GT31022	01/2024	12/2025	OMEGA PHARMA KhasraNo.-482, Village-Saliyar, Roorkee-247667, Distt.-Haridwar (Uttarakhand)	Related substances	CDTL-Mumbai
16.	Extuss-D (Dextromethorp han HBR, Chlorpheniramin e Maleate & Phenylephrine HCL Syrup)	2402168	02/2024	01/2026	Brij Healthcare Pvt. Ltd., 51/10, G.I.D.C Estate, Motipura, Himatnagar, Gujarat 383001	Assay of Phenylephrin e Hydrochloride	CDTL-Mumbai
17.	IRON & FOLIC ACID SYRUP IP	RIFS-209	04/2024	09/2026	M/s. Revat Laboratories Pvt. Ltd., Works at : 12-321, Opp. I.D.A, Kurnool Road, Pernamitta, Ongole-523002	pH and Assay of Folic Acid	CDTL, Hyderabad
18.	Prednisolone Tablets IP 10 mg	PRDT- 1007	11/2024	10/2024	WINGS BIOTECH LLP, 43 & 44, HPSIDC, Industrial Area, Baddi-173205 (H.P.)	Assay of Prednisolone	RDTL Chandigarh
19.	Aloevera, Glycerin and Vitamin-E Soap (D-Soft Soap)	COS-130	03/2024	02/2026	Samanyu Skin Care, Plot No. 191, HPSIDC, Baddi, Distt. Solan (H.P.)-1732025	Matter insoluble in alochol	RDTL Chandigarh
20.	Aloevera, Glycerin, Vitamin-E and Jojoba oil (Synmoist Soap)	COS-132	03/2024	02/2026	Samanyu Skin Care, Plot No. 191, HPSIDC, Baddi, Distt. Solan (H.P.)-1732025	Matter insoluble in alochol	RDTL Chandigarh

21.	Aloevera+Glyce rin+Almond Oil and Vitamin-E Soap (Aqualux Soap)	COS-131	03/2024	02/2026	Samanyu Skin Care, Plot No. 191, HPSIDC, Baddi, Distt. Solan (H.P.)-1732025	Matter insoluble in alochol	RDTL Chandigarh
22.	Fexofenadine Hydrochloride Tablets IP (MANOFEX-180 TABLETS)	CT232407 15A	08/2023	07/2025	CMG BIOTECH PVT. LTD., (Unit-II) Plot No. 58, Phase III, Industrial Area, Sansarpur Terrac HP-176501	Dissolution (In 10 minutes) and (in 30 minutes)	RDTL Chandigarh
23.	Norfloxacin Oral Suspension (Ridnor Suspension)	RL230022	03/2023	02/2025	RIDLEY LIFE SCIENCE PVT. LTD., Unit II : D-1566 DSIDC, Ind. Complex, Narela, Delhi-110040	Description and Total Fungal Count	RDTL Chandigarh
24.	Albendazole Tablets IP	MS1AO22 01	07/2022	06/2025	MAXTAR BIO- GENICS, Khasra No. 705, Vill. Malku Majra, Nalagarh Road, Baddi, Distt.Solan-173205 (H.P.)-India	Dissolution	RDTL Chandigarh
25.	Pantoprazole Gastro- Resistant Tablets IP 40 mg.	PGR-07	01/2024	12/2025	Agron Remedies Pvt. Ltd., Sarverkhera, Moradabad Road, Kashipur-244713 (Uttarakhand)	Dissolution	RDTL, Guwahati
26.	Co-trimoxazole Tablets IP (S- tron Tablets SS)	ST-223	06/2023	05/2025	High Tech Pharma, 49, Khandelwal compound, Palda, Indore (MP)	Dissolution (Trimethopri m and Sulphametho xazole)	RDTL, Guwahati
27.	Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP (Levmont)	ST23- 384D	05/2023	04/2025	M/s Symbiosis Pharmaceuticals Pvt. Ltd.,, Suketi Road, Kala Amb Distt. Sirmour, Himachal Pradesh – 173030	Dissolution of Montelukast Levocetirizine hydrochloride	RDTL, Guwahati
28.	Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP	23112701	03/2023	02/2025	MERCURY LABORATORIES LIMITED., Unit No.2, Halol Baroda Road, Village: Jarod. Tal: Waghodia, Dist: Vadodara- 391510	Dissolution of Montelukast	RDTL, Guwahati
29.	Iron and Folic Acid Syrup IP	IFIS23015	08/2023	01/2025	Galpha Laboratories Limited, Village- Thana, Baddi, Himachal Pradesh- 173205	Assay of Folic Acid	RDTL, Guwahati
30.	Etoricoxib Tablets I.P. 90 mg.	ECX-2304	08/2023	07/2025	Apple Formulations Private Limited, Plot No. 208, Kishanpur, Roorkee – 247667 (U.K.)	Dissolution	RDTL, Guwahati
31.	Mannitol Injection I.P. (20% w/v)	M1M30038	07/2023	06/2025	Kunal Remedies Pvt. Ltd., Khasra 284, Vill. Anaura Kala Faizabad Road, Lucknow 226028, (UP), India	Test for Sterility	RDTL, Guwahati

List of Drugs declared as NSQ by STATES for the Month of June– 2024.

B. State Laboratories
S.No	Product/Drug Name	Batch No.	Manufacturing Date	Expiry Date	Manufactured By	NSQ Result	Reported by CDSCO Laboratory
1.	Liquid Paraffin IP	EP4032	01/24	12/26	Repacked by :- Kerala State Drugs & Pharmaceuticals Ltd, Kalavoor.P.O, Alappuzha	It fails the test light absorption as per IP	Drugs Testing Laboratory Thiruvananthapura m
2.	Losartan Potassium Tablets IP 50 mg	HLOA06	11/23	10/25	Hindustan Antibiotics Ltd, at II, W.E.A, Faridabad- 121 001(Haryana) R.O, Pimpri, Pune -411 018	It fails the test ‘Dissolution’ as per IP	Drugs Testing Laboratory Thiruvananthapura m
3.	Amloheart-AT [Amlodipine Besylate and Atenolol Tablets]	LE223030	03/23	02/25	Lividus Pharmaceuticals pvt.Ltd, ikeva, Level2, Agnito Tech park,141 Kandachavadi, Near, Perungudi, OMR, Chennai-600096	It fails the test ‘Assay’ of Amlodipine Besylate	Drugs Testing Laboratory Thiruvananthapura m
4.	Bacotil-200 [Cefpodoxime Proxetil Tablets USP ]	ZTB-148	03/24	02/26	Zenith Healthcare Ltd works: 388/34, Changodarlnd. Estate, Sarkhej Bavla Highway, Changodar- 382213 (Gujarat)	It fails the test ‘Dissolution’ as per USP	Drugs Testing Laboratory Thiruvananthapura m
5.	Oseltamivir Cap IP 75 mg	D 0444/24- 25			Supplied by Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14	The sample does not conform to IP standard with respect to the ‘Descriptive part’ of hard gelatin capsules	Drugs Testing Laboratory Thiruvananthapura m
6.	Haridrakhandam	207/23	03/24	02/26	Bhaskaravilasam Vaidyasala, Panayamuttom, Nedumangadu Thiruvananthapuram 695 561	It fails the test ‘pH’ as per API	Drugs Testing Laboratory Thiruvananthapura m
7.	Yogarajaguggulu	209/21	03/22	3 yrs from the date of mfg	Bhaskaravilasam Vaidyasala, Panayamuttom, Nedumangadu, Thiruvananthapuram 695 561	It fails the test ‘Alcohol soluble Extractive and pH’ as per API	Drugs Testing Laboratory Thiruvananthapura m
8.	CANDITRAL 100 (ITRACONAZOLE CAPSULE B.P. 100 MG)	5230123	Jan-23	Jun-25	GLENMARK PHARMACEUTICALS LTD.	THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TEST	Maharashtra
9.	Lytraco 200 Itraconazole Capsules 200 mg	SLP-22445	Feb-23	Jan-25	STERLIFE PHARMA PVT. LTD.	THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TEST THE SAMPLE IS OFFICIAL IN B P 2021 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE 96 OF THE DRUGS AND COSMETICS ACT 1940 AND RULES 1945.	Maharashtra
10.	MONTOR -LC TABLET (MONTELUKAST SODIUM & LEVOCETRIZINE DIHYDROCHLORI DE TABLET I.P.)	B18523001	Jan-23	Dec-24	TORQUE PHARMACEUTICALS PVT. LTD.	THE SAMPLE DOES NOT COMPLY WITH I P REQUIREMENTS FOR DISSOLUTION TEST	Maharashtra

11.	MONTICET-L Tablets ( Montelukast & Levocetirizine Hydrochloride Tablets)	TP-7581	Sep-22	Aug-24	TICOMA PHARMACIA	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST. THE SAMPLE IS OFFICIAL IN 1 P 2018 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE 96 OF THE DRUGS AND COSMETICS ACT 1940 AND RULES 1945.	Maharashtra
12.	Levocetrizine Dihydrochloride & Montelukast Sodium Tablets I.P. Zeemont	T22H370C	Aug-22	Jul-24	Bajaj Formulations	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST.	Maharashtra
13.	VolKast Kid Syrup 60 ml.	ABS- 2301022	Jan-23	Dec-24	Amentis Biotech Pvt. Ltd.	CONTENT OF MONTELUKAST AND LEVOCETIRIZINE GYDROCHLORIDE IN THE SAMPLE IS LESS (i.e. MONTELUKAST IS 10.50% AND LEVOCETIRIZINE HYDROCHLORIDE IS 71.88% OF THE STATED AMOUNT) THAN THE PERMISSIBLE LIMITS.	Maharashtra
14.	Levetiracetam Tablets U.S.P.500 Mg (LEVEEG-500)	T23D050A	Apr-23	Mar-25	BAJAJ FORMULATIONS	THE SAMPLE DOES NOT COMPLY WITH USP REQUIREMENTS FOR DISSOLUTION.	Maharashtra
15.	M2 Pan-DSR (Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP)	CWHC-283	Oct-22	Sep-24	COSWAY PHARMACEUTICALS	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION OF PANTOPRAZOLE AT ACID STAGE	Maharashtra
16.	Omeford – 40	SNT-220421	Sep-22	Aug-24	SVR HEALTHCARE (A GMP Certified Company)	THE CONTENT OF OMEPRAZOLE IN THE SAMPLE IS LESS (l.e. 40.84% OF LABELLED AMOUNT) THAN THE SCHEDULE V LIMITS	Maharashtra
17.	COZOL- D(Omeprazole with Domperidone Capsules)	AC1952	Jul-23	Jun-25	ALICON PHARMACEUTICAL PVT LTD	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE). THE SAMPLE IS OFFICIAL IN IP.	Maharashtra
18.	DRPLAN-DSR (Pantoprazole Gasto-resistant & Domperidone Prolonged-release Capsules IP)	AC2209003A	Sep-22	Aug-24	ADDII BIOTECH PVT. LTD.	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE) .	Maharashtra
19.	SOFTOM-D Omeprazole and Domperidone Capsules IP	UD2C- 23252B	Apr-23	Mar-25	ULTRA DRUGS PVT. LTD. (UNIT-II)	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).	Maharashtra
20.	OMEPRAZOLE & DOMPERIDONE CAPSULES (REMIZOLE-D)	SPC230578 C	Mar-23	Feb-25	SALUS PHARMACEUTICALS	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).	Maharashtra

21.	PANTOPRAZOLE (EC) & DOMPERIDONE (SR) CAPSULES IP (PANTIAC-DSR)	PTRC-149	Feb-23	Jan-25	IOSIS REMEDIES PVT. LTD.	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE)	Maharashtra
22.	DYNACID SUSPENSION (aluminium, magnesium & simethicone oral suspension IP.)	BULH23008	Apr-23	Mar-25	Leeford Healthcare Ltd.	1) THE SAMPLE DOES NOT COMPLY WITH I.P. REQUIREMENTS FOR TOTAL AEROBIC VIABLE	Maharashtra
						COUNT IN TEST FOR MICROBIAL CONTAMINATION. 2) TOTAL AEROBIC VIABLE COUNT OF THE SAMPLE IS 20993128 CFU/GM. (1.P. LIMIT-TOTAL AEROBIC VIABLE COUNT OF THE SAMPLE – NOT MORE THAN 100 CFU/GM
23.	ELTHROM-200 (Azithromycin oral suspension IP) 15ML	G-042/5045	May-23	Apr-25	ELFIN DRUGS PVT. LTD.	CONTENT OF AZITHROMYCIN IN THE SAMPLE IS LESS (72.96% OF LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT-90.0%- 110.0%)	Maharashtra
24.	Alpracan 0.5 Tablets (Alprazolam Tablets)	T2455	Oct-22	Sep-25	Evolet Pharmaceutical Pvt. Ltd.	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR ALPRAZOLAM TABLETS FOR THE DISSOLUTION TEST WITH RESPECT TO ABOVE PROTOCOL.	Maharashtra
25.	RABEPP TABLETS (Rabeprazole Sodium Tablets IP)	ATG2K135	Nov-22	Oct-24	ANROSE PHARMA	CONTENT OF RABEPRAZOLE SODIUM IM THE SAMPLE IS LESS (65.04% OF THE LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT 90.0% – 110.0%)	Maharashtra
26.	INFI-650 TABLETS (PARACETAMOL TABLETS I.P. 650 mg)	AT-100008	Dec-22	Nov-25	ABARIS HEALTHCARE	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST.	Maharashtra
27.	CUCID-DM	CDMC501	May-23	Apr-25	TULBROS FORMULATIONS	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR OMEPRAZOLE IN ACID STAGE.	Maharashtra
28.	Virpan-40	T-2306031A	Jun-23	May-25	WHITE ENGLE LABORATORIES	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION IN BUFFER STAGE.	Maharashtra
29.	Pantakos-40 (Pantoprazole Gastro-resistant Tablets IP )	CCT231092 B	Sep-23	Aug-25	Cent Cure Pvt Ltd.	THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION IN BUFFER STAGE.	Maharashtra
30.	Rosumep ASP 10/75mg Capsules	PBWGM04	Sep-23	Aug-25	Pure & Care Healthcare Pvt. Ltd.	THE SAMPLE DOES NOT COMPLY WITH IP FOR THE TEST “RELATED SUBSTANCES – ROSUVASTATIN”.	Maharashtra

NOTE:

1. NSQ data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Rajasthan (PDF format) and Orissa (PDF Format). for the Month of June, 2024 as per DCG(I) Circular dated 09.02.2024.
2. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh,Goa,Gujarat, Haryana, Himachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry,Telangana,Delhi,Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of June, 2024 as per DCG(I) Circular dated 09.02.2024.

---

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• USFDA issues warning letter to Sanofi
  January 22, 2025
• Telangana cracks down on illegal sale of Bodybuilding drugs
  January 22, 2025
• Fire breakout at pharma plant in Andhra
  January 21, 2025
• New guidelines for approval of IVDs: CDSCO
  January 21, 2025
• Key Notes on Revised Schedule M: Radiopharmaceutical Products
  January 20, 2025
• Drug Testing Laboratory upgraded: Pondicherry
  January 20, 2025

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: